SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
Valuation | |
---|---|
Market Cap ($M) | 132.64 |
Enterprise Value ($M) | 125.65 |
Book Value ($M) | 81.42 |
Book Value / Share | 1.07 |
Price / Book | 1.63 |
NCAV ($M) | 65.78 |
NCAV / Share | 0.87 |
Price / NCAV | 2.02 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.61 |
Return on Assets (ROA) | -0.44 |
Return on Equity (ROE) | -0.55 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 7.63 |
Current Ratio | 7.63 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 90.30 |
Assets | 105.94 |
Liabilities | 24.52 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.35 |
Operating Income | -54.92 |
Net Income | -50.39 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -33.22 |
Cash from Investing | -20.13 |
Cash from Financing | 66.23 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Lytton Laurence W | 1.00 | -86.82 | |
13G/A | Stonepine Capital Management, LLC | 0.80 | -89.83 | |
13G/A | Fmr Llc | 15.00 | 101.87 | |
13G/A | Federated Hermes, Inc. | 17.37 | 94.39 | |
13G | Logos Global Management LP | 9.90 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
113,443 | 754,883 | 15.03 | |
127,577 | 494,135 | 25.82 | |
29,568 | 135,860 | 21.76 | |
41,579 | 316,442 | 13.14 | |
(click for more detail) |
Similar Companies | |
---|---|
ATNF – 180 Life Sciences Corp. | ATOS – Atossa Therapeutics, Inc. |
ATXI – Avenue Therapeutics, Inc. | AVTX – Avalo Therapeutics, Inc. |
AWH – Aspira Women's Health Inc. |
Financial data and stock pages provided by
Fintel.io